Publications by authors named "Jun-Shik Hong"
Article Synopsis
- The study assessed the long-term outcomes of patients with gastric MALT lymphoma, focusing on overall survival and remission rates over time.
- A total of 153 patient records from 2013 to 2020 were analyzed, revealing that factors like older age, being male, and higher clinical stages were linked to more aggressive disease progression.
- Results indicated a high 5-year survival rate of 97.7% and an 88.3% continuous remission rate, suggesting that most patients experience indolent disease even though some may have aggressive presentations.
Background: Carbapenem is frequently used when gram negative bacilli (GNB) bacteremia is detected especially in neutropenic patients. Consequently, appropriate treatment could be delayed in GNB bacteremia cases involving organisms which are not susceptible to carbapenem (carba-NS), resulting in a poor clinical outcomes. Here, we explored risk factors for carba-NS GNB bacteremia and its clinical outcomes in patients with acute myelogenous leukemia (AML) that underwent chemotherapy.
View Article and Find Full Text PDFBackground: Rituximab plus cyclophosphamide, vincristine, and prednisone (R-CVP) is one of the effective chemotherapeutic regimens for patients with advanced stage marginal zone lymphoma (MZL). However, prognostic factors that affect the outcome of treatment for MZL are not well understood.
Methods: Between August 2006 and June 2013, patients with newly diagnosed stage III and IV MZL treated with R-CVP as a first-line therapy from 15 institutions were retrospectively analyzed.
Background: Mutations in calreticulin (CALR) have been reported to be key markers in the molecular diagnosis of myeloid proliferative neoplasms. In most previous reports, CALR mutations were analyzed by using Sanger sequencing. Here, we report a new, rapid, and convenient system for screening CALR mutations without sequencing.
View Article and Find Full Text PDFThe hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (hyper-CVAD) regimen has been widely used for lymphoblastic lymphoma (LBL) as a primary treatment. However, there is few data about its treatment outcome in Asian patients. Thus, we conducted this study to evaluate the efficacy of hyper-CVAD induction and stem cell transplantation (SCT) consolidation in LBL patients.
View Article and Find Full Text PDFArticle Synopsis
- Recent studies suggest that metabolic tumor volume (MTV) measured by PET/CT is a valuable predictor of prognosis in patients with non-Hodgkin's lymphoma, but its impact on early-stage Hodgkin's lymphoma treatment is unclear.
- A study included 127 patients with early-stage Hodgkin's lymphoma, comparing outcomes of those treated with only ABVD chemotherapy versus those receiving combined modality therapy (CMT), indicating that higher MTV is linked to poorer survival rates regardless of treatment.
- Results showed that ABVD alone effectively controlled disease in patients with low MTV, while high MTV patients had worse survival outcomes, suggesting MTV is crucial for treatment decisions in early-stage Hodgkin's lymphoma.
Radioiodine is regularly used in the treatment of thyroid cancer to eliminate residual malignant tissue after thyroidectomy and to treat metastasis. Because of the low dose of radioiodine used to treat thyroid cancer patients, leukemia is an uncommon complication of exposure to radioiodine. Here, we present a patient who developed therapy-related acute myeloid leukemia with inv(16)(p13.
View Article and Find Full Text PDF